[1]
K. Matsui, K. Tachioka, K. Onodera, and R. Ikeda, “Topical Application of Josamycin Inhibits Development of Atopic Dermatitis-Like Skin Lesions in NC/Nga Mice”, J Pharm Pharm Sci, vol. 20, pp. 38–47, Mar. 2017.